Clinical trial
Methadone Versus Intrathecal Hydromorphone for Postoperative Analgesia in Patients Undergoing Surgery for Gynecologic Malignancy Via Midline Laparotomy Receiving Liposomal Bupivacaine
NCT06525740 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Methadone Versus Intrathecal Hydromorphone for Postoperative Analgesia in Patients Undergoing Surgery for Gynecologic Malignancy Via Midline Laparotomy Receiving Liposomal Bupivacaine
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 3, 2024
- Completion date
- September 1, 2029
- Enrollment
- 140 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malignant female reproductive system neoplasm